{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:34:00Z","timestamp":1783791240600,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s13760-023-02373-0","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T06:01:51Z","timestamp":1693893711000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spectrum of various CNS inflammatory demyelination diseases following COVID-19 vaccinations"],"prefix":"10.1007","volume":"124","author":[{"given":"Manish","family":"Salunkhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Tayade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Priyadarshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7662-3202","authenticated-orcid":false,"given":"Rohit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V. Padma","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"2373_CR1","unstructured":"WHO (World Health Organization). https:\/\/covid19.who.int\/"},{"key":"2373_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA et al (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397:99\u2013111. https:\/\/doi.org\/10.1016\/S0140-6736(20)32661-1","journal-title":"Lancet"},{"key":"2373_CR3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S1473-3099(21)00070-0","volume":"21","author":"R Ella","year":"2021","unstructured":"Ella R, Reddy S, Jogdand H et al (2021) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis 21:950\u2013961. https:\/\/doi.org\/10.1016\/S1473-3099(21)00070-0","journal-title":"Lancet Infect Dis"},{"key":"2373_CR4","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/nejmoa2028436","volume":"383","author":"EJ Anderson","year":"2020","unstructured":"Anderson EJ, Rouphael NG, Widge AT et al (2020) Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 383:2427\u20132438. https:\/\/doi.org\/10.1056\/nejmoa2028436","journal-title":"N Engl J Med"},{"key":"2373_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00292-w","author":"NC Kyriakidis","year":"2021","unstructured":"Kyriakidis NC, L\u00f3pez-Cort\u00e9s A, Gonz\u00e1lez EV et al (2021) SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. NPJ Vaccines. https:\/\/doi.org\/10.1038\/s41541-021-00292-w","journal-title":"NPJ Vaccines"},{"key":"2373_CR6","unstructured":"CoWIN. https:\/\/www.cowin.gov.in\/. Accessed 15 Dec 2022"},{"key":"2373_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05662-9","volume-title":"Spectrum of neurological complications following COVID-19 vaccination","author":"RK Garg","year":"2022","unstructured":"Garg RK, Paliwal VK (2022) Spectrum of neurological complications following COVID-19 vaccination. Springer International Publishing"},{"key":"2373_CR8","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1007\/s10072-022-06000-3","volume":"43","author":"BV Maramattom","year":"2022","unstructured":"Maramattom BV, Lotlikar RS, Sukumaran S (2022) Central nervous system adverse events after ChAdOx1 vaccination. Neurol Sci 43:3503\u20133507. https:\/\/doi.org\/10.1007\/s10072-022-06000-3","journal-title":"Neurol Sci"},{"key":"2373_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"2373_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"2373_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 22:268\u2013282. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"2373_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP et al (2013) International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler J 19:1261\u20131267. https:\/\/doi.org\/10.1177\/1352458513484547","journal-title":"Mult Scler J"},{"key":"2373_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/WCO.0000000000000683","volume":"32","author":"TA Hardy","year":"2019","unstructured":"Hardy TA (2019) Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome. Curr Opin Neurol 32:467\u2013474. https:\/\/doi.org\/10.1097\/WCO.0000000000000683","journal-title":"Curr Opin Neurol"},{"key":"2373_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","volume":"13","author":"D Karussis","year":"2014","unstructured":"Karussis D, Petrou P (2014) The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev 13:215\u2013224. https:\/\/doi.org\/10.1016\/j.autrev.2013.10.003","journal-title":"Autoimmun Rev"},{"key":"2373_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ana.26065","volume":"89","author":"AL Goss","year":"2021","unstructured":"Goss AL, Samudralwar RD, Das RR, Nath A (2021) ANA investigates: neurological complications of COVID-19 vaccines. Ann Neurol 89:856\u2013857. https:\/\/doi.org\/10.1002\/ana.26065","journal-title":"Ann Neurol"},{"key":"2373_CR16","doi-asserted-by":"publisher","first-page":"577765","DOI":"10.1016\/j.jneuroim.2021.577765","volume":"362","author":"II Ismail","year":"2022","unstructured":"Ismail II, Salama S (2022) A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol 362:577765. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577765","journal-title":"J Neuroimmunol"},{"key":"2373_CR17","unstructured":"Netravathi M, Dhamija K, Gupta M et al (2020) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\u2019s public news and information"},{"key":"2373_CR18","doi-asserted-by":"publisher","first-page":"104141","DOI":"10.1016\/j.msard.2022.104141","volume":"68","author":"KH Kim","year":"2022","unstructured":"Kim KH, Kim SH, Park NY et al (2022) Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations. Mult Scler Relat Disord 68:104141. https:\/\/doi.org\/10.1016\/j.msard.2022.104141","journal-title":"Mult Scler Relat Disord"},{"key":"2373_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13:1\u201345. https:\/\/doi.org\/10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"2373_CR20","doi-asserted-by":"publisher","first-page":"251513552211150","DOI":"10.1177\/25151355221115016","volume":"10","author":"M Otiv","year":"2022","unstructured":"Otiv M, Botre A, Shah P (2022) Measles\u2013rubella vaccine\u2013associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. Ther Adv Vaccines Immunother 10:251513552211150. https:\/\/doi.org\/10.1177\/25151355221115016","journal-title":"Ther Adv Vaccines Immunother"},{"key":"2373_CR21","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1007\/s00415-022-11194-9","volume":"269","author":"S Jarius","year":"2022","unstructured":"Jarius S, Bieber N, Haas J, Wildemann B (2022) MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. J Neurol 269:5198\u20135212. https:\/\/doi.org\/10.1007\/s00415-022-11194-9","journal-title":"J Neurol"},{"key":"2373_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00415-021-10780-7","volume":"269","author":"M Khayat-Khoei","year":"2022","unstructured":"Khayat-Khoei M, Bhattacharyya S, Katz J et al (2022) COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol 269:1093\u20131106. https:\/\/doi.org\/10.1007\/s00415-021-10780-7","journal-title":"J Neurol"},{"key":"2373_CR23","doi-asserted-by":"publisher","first-page":"577785","DOI":"10.1016\/j.jneuroim.2021.577785","volume":"362","author":"K Toljan","year":"2022","unstructured":"Toljan K, Amin M, Kunchok A, Ontaneda D (2022) New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure. J Neuroimmunol 362:577785. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577785","journal-title":"J Neuroimmunol"},{"key":"2373_CR24","first-page":"1","volume":"150","author":"M Yamakawa","year":"2020","unstructured":"Yamakawa M, Kuno T, Mikami T et al (2020) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company \u2019 s public news and information. J Neurol Sci 150:1\u20139","journal-title":"J Neurol Sci"},{"key":"2373_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/ene.15147","volume":"29","author":"LD Kaulen","year":"2022","unstructured":"Kaulen LD, Doubrovinskaia S, Mooshage C et al (2022) Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series. Eur J Neurol 29:555\u2013563. https:\/\/doi.org\/10.1111\/ene.15147","journal-title":"Eur J Neurol"},{"key":"2373_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-06686-z","author":"M Salunkhe","year":"2023","unstructured":"Salunkhe M, Gupta P, Singh RK et al (2023) Clinical and radiological spectrum of anti-myelin oligodendrocyte glycoprotein (MOG) antibody encephalitis: single-center observational study. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-023-06686-z","journal-title":"Neurol Sci"},{"key":"2373_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26549","author":"C Valencia-Sanchez","year":"2022","unstructured":"Valencia-Sanchez C, Guo Y, Krecke KN et al (2022) Cerebral cortical encephalitis in MOGAD. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.26549","journal-title":"Ann Neurol"},{"key":"2373_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940715","author":"F Dotiwala","year":"2022","unstructured":"Dotiwala F, Upadhyay AK (2022) A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.940715","journal-title":"Front Immunol"},{"key":"2373_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2022.845755","volume":"13","author":"Y Matsumoto","year":"2022","unstructured":"Matsumoto Y, Ohyama A, Kubota T et al (2022) MOG antibody-associated disorders following SARS-CoV-2 vaccination: a case report and literature review. Front Neurol 13:1\u20136. https:\/\/doi.org\/10.3389\/fneur.2022.845755","journal-title":"Front Neurol"},{"key":"2373_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnhum.2021.656313","volume":"15","author":"H Yapici-Eser","year":"2021","unstructured":"Yapici-Eser H, Koroglu YE, Oztop-Cakmak O et al (2021) Neuropsychiatric symptoms of COVID-19 explained by SARS-CoV-2 proteins\u2019 mimicry of human protein interactions. Front Hum Neurosci 15:1\u201316. https:\/\/doi.org\/10.3389\/fnhum.2021.656313","journal-title":"Front Hum Neurosci"},{"key":"2373_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068373","author":"X Li","year":"2022","unstructured":"Li X, Ravent\u00f3s B, Roel E et al (2022) Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. The BMJ. https:\/\/doi.org\/10.1136\/bmj-2021-068373","journal-title":"The BMJ"},{"key":"2373_CR32","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","volume":"27","author":"M Patone","year":"2021","unstructured":"Patone M, Handunnetthi L, Saatci D et al (2021) Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med 27:2144\u20132153. https:\/\/doi.org\/10.1038\/s41591-021-01556-7","journal-title":"Nat Med"},{"key":"2373_CR33","doi-asserted-by":"publisher","first-page":"104032","DOI":"10.1016\/j.msard.2022.104032","volume":"66","author":"VR Ostovan","year":"2022","unstructured":"Ostovan VR, Sahraian MA, Karazhian N et al (2022) Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: a systematic review. Mult Scler Relat Disord 66:104032. https:\/\/doi.org\/10.1016\/j.msard.2022.104032","journal-title":"Mult Scler Relat Disord"},{"key":"2373_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103424","author":"I Nmosd","year":"2022","unstructured":"Nmosd I (2022) Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD. Mult Scler Relat Disord. https:\/\/doi.org\/10.1016\/j.msard.2021.103424","journal-title":"Mult Scler Relat Disord"},{"key":"2373_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103827","author":"A Dinoto","year":"2022","unstructured":"Dinoto A, Gastaldi M, Iorio R et al (2022) Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders. Mult Scler Relat Disord. https:\/\/doi.org\/10.1016\/j.msard.2022.103827","journal-title":"Mult Scler Relat Disord"},{"key":"2373_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/jnnp-2021-327340","volume":"93","author":"C Crossette-Thambiah","year":"2022","unstructured":"Crossette-Thambiah C, Pericleous C, Asmar N et al (2022) Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. J Neurol Neurosurg Psychiatry 93:445\u2013448. https:\/\/doi.org\/10.1136\/jnnp-2021-327340","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02373-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-023-02373-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02373-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T16:08:28Z","timestamp":1708186108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-023-02373-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2373"],"URL":"https:\/\/doi.org\/10.1007\/s13760-023-02373-0","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"15 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}